Cargando…

Serum creatinine/cystatin C ratio as a surrogate marker for sarcopenia in patients with gastric cancer

BACKGROUND: Sarcopenia is an age-related syndrome that may have negative impact on surgical outcomes and long-term survival of patients with gastric cancer. Serum creatinine/cystatin C (Cr/CysC) ratio has attracted attention as a surrogate marker for sarcopenia but has not been adequately studied in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Jing, Yang, Hui, Cai, Wentao, Zheng, Jingwei, Shen, Ningzhe, Yang, Xinxin, Pan, Bujian, Zhang, Weiteng, Chen, Xiaodong, Shen, Xian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8772102/ https://www.ncbi.nlm.nih.gov/pubmed/35045814 http://dx.doi.org/10.1186/s12876-022-02093-4

Ejemplares similares

Serum creatinine/cystatin C ratio is a surrogate marker for sarcopenia in patients with idiopathic pulmonary fibrosis
por: Fujita, Kohei, et al.
Publicado: (2022)

MON-LB073 The Serum Creatinine to Serum Cystatin C Ratio Is a Reliable Surrogate Marker of Sarcopenia in Patients with Cushing's Syndrome in Remission
por: Martel, Luciana, et al.
Publicado: (2019)

Serum creatinine/cystatin C ratio is a systemic marker of sarcopenia in patients with gastrointestinal stromal tumours
por: Ding, Ping’an, et al.
Publicado: (2022)

Establishment of the Radiologic Tumor Invasion Index Based on Radiomics Splenic Features and Clinical Factors to Predict Serous Invasion of Gastric Cancer
por: Pan, Bujian, et al.
Publicado: (2021)

Sarcopenia and myosteatosis diagnostic tool for gastrointestinal cancer: creatinine to cystatin C ratio as evaluation marker
por: Liu, Hao, et al.
Publicado: (2023)

Clinical significance of serum cystatin C‐to‐creatinine ratio as a surrogate marker for incident osteoporotic fracture predictions
por: Yoshii, Ichiro, et al.
Publicado: (2023)

Serum creatinine/cystatin C ratio as a screening tool for sarcopenia and prognostic indicator for patients with esophageal cancer
por: Zheng, Chao, et al.
Publicado: (2022)

Prognostic value of the preoperative albumin‐bilirubin score among patients with stages I–III gastric cancer undergoing radical resection: A retrospective study
por: Wang, Xiang, et al.
Publicado: (2023)

Serum cystatin C to creatinine ratio is associated with sarcopenia in non-dialysis-dependent chronic kidney disease
por: An, Jung Nam, et al.
Publicado: (2022)

Creatinine-to-cystatin C ratio as a marker of sarcopenia for identifying osteoporosis in male patients with type 2 diabetes mellitus
por: Dai, Huifan, et al.
Publicado: (2022)

Preoperative Albumin-Bilirubin Grade as a Prognostic Predictor in Colorectal Cancer Patients Who Undergo Radical Resection
por: Zhu, Ce, et al.
Publicado: (2020)

Correction: Creatinine‑to‑cystatin C ratio as a marker of sarcopenia for identifying osteoporosis in male patients with type 2 diabetes mellitus
por: Dai, Huifang, et al.
Publicado: (2022)

Global leaders malnutrition initiative-defined malnutrition affects long-term survival of different subgroups of patients with gastric cancer: A propensity score-matched analysis
por: Cai, Wentao, et al.
Publicado: (2022)

A Novel Application of Serum Creatinine and Cystatin C to Predict Sarcopenia in Advanced CKD
por: Lin, Yu-Li, et al.
Publicado: (2022)

Sarcopenia index based on serum creatinine and cystatin C predicts the risk of postoperative complications following hip fracture surgery in older adults
por: Chen, Xiaoyan, et al.
Publicado: (2021)

Efficacy of the Preoperative Albumin–Bilirubin Grade for Predicting Survival and Outcomes of Postoperative Chemotherapy for Advanced Gastric Cancer
por: Zhu, Ce, et al.
Publicado: (2020)

Sarcopenia Index Based on Serum Creatinine and Cystatin C is Associated with Mortality, Nutritional Risk/Malnutrition and Sarcopenia in Older Patients
por: Ren, Chenxi, et al.
Publicado: (2022)

Serum creatinine and cystatin C‐based diagnostic indices for sarcopenia in advanced non‐small cell lung cancer
por: Tang, Tianjiao, et al.
Publicado: (2022)

Sarcopenia index based on serum creatinine and cystatin C is associated with 3-year mortality in hospitalized older patients
por: Tang, Tianjiao, et al.
Publicado: (2020)

Sarcopenia in Patients With Normal Body Mass Index Is an Independent Predictor for Postoperative Complication and Long‐Term Survival in Gastric Cancer
por: Sun, Xiangwei, et al.
Publicado: (2021)

Diagnostic Value of Serum Creatinine and Cystatin-C-Based Indices and Ishii Score in Cancer-Related Sarcopenia
por: Ding, Liming, et al.
Publicado: (2023)

Utility of serum creatinine/cystatin C ratio in diagnosis of postrenal acute kidney injury
por: İnal, Salih, et al.
Publicado: (2014)

Serum creatinine/cystatin C ratio as a prognostic indicator for patients with colorectal cancer
por: Gao, Shunhui, et al.
Publicado: (2023)

Sarcopenia is associated with the neutrophil/lymphocyte and platelet/lymphocyte ratios in operable gastric cancer patients: a prospective study
por: Lin, Ji, et al.
Publicado: (2018)

Serum creatinine to cystatin C ratio and cognitive function among middle-aged and older adults in China
por: Zhu, Yueli, et al.
Publicado: (2022)

A sarcopenia index based on serum creatinine and cystatin C cannot accurately detect either low muscle mass or sarcopenia in urban community-dwelling older people
por: He, Qian, et al.
Publicado: (2018)

Serum Creatinine-to-Cystatin C Ratio in the Progression Monitoring of Non-alcoholic Fatty Liver Disease
por: Li, Shaobo, et al.
Publicado: (2021)

Reference Intervals of Spot Urine Creatinine-to-Osmolality Ratio as a Surrogate of Urinary Creatinine Excretion Rate
por: Hsu, Shih-Ping, et al.
Publicado: (2022)

Creatinine–cystatin C ratio and mortality in cancer patients: a retrospective cohort study
por: Jung, Chan‐Young, et al.
Publicado: (2022)

Relationship between serum creatinine to cystatin C ratio and subclinical atherosclerosis in patients with type 2 diabetes
por: Hashimoto, Yoshitaka, et al.
Publicado: (2022)

Serum creatinine to cystatin C ratio and clinical outcomes in adults with non-dialysis chronic kidney disease
por: Hyun, Young Youl, et al.
Publicado: (2022)

The serum creatinine to cystatin C ratio predicts the risk of acute exacerbation of chronic obstructive pulmonary disease
por: He, Liang, et al.
Publicado: (2023)

Serum-Creatinine-to-Cystatin C-to-Waist-Circumference Ratios as an Indicator of Severe Airflow Limitation in Older Adults
por: Li, Jinxuan, et al.
Publicado: (2023)

A New Index Based on Serum Creatinine and Cystatin C Can Predict the Risks of Sarcopenia, Falls and Fractures in Old Patients with Low Bone Mineral Density
por: Ge, Jiaying, et al.
Publicado: (2022)

Serum Cystatin C as a Marker of Renal Function in Critically Ill Patients With Normal Serum Creatinine
por: Sagheb, Mohammad Mahdi, et al.
Publicado: (2014)

Relationships between cystatin C- and creatinine-based eGFR in Japanese rural community- dwelling older adults with sarcopenia
por: Kusunoki, Hiroshi, et al.
Publicado: (2020)

Serum Creatinine to Cystatin C Ratio is an Effective Indicator for Muscle Strength Decline in Men with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Huang, Dan, et al.
Publicado: (2022)

The Ratio of Estimated Glomerular Filtration Rate Based on Cystatin C and Creatinine Reflecting Cardiovascular Risk in Diabetic Patients
por: Khang, Ah Reum, et al.
Publicado: (2023)

Usefulness of serum creatinine and cystatin C ratio as a screening tool for predicting prognosis in patients with pancreatic cancer
por: Tsukagoshi, Mariko, et al.
Publicado: (2023)

Age- and sex-specific reference intervals for the serum cystatin C/creatinine ratio in healthy children (0–18 years old)
por: Liu, Changjin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ep7t9rica3peuio4agb5np757k